Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.

Hanneke C. Kluin-Nelemans,Eva Hoster,Olivier Hermine,Jan Walewski,Christian H. Geisler,Marek Trneny,Stephan Stilgenbauer,Florian Kaiser,Jeanette K. Doorduijn,Gilles Salles,Michal Szymczyk,Hervé Tilly,Lothar Kanz,Christian Schmidt,Pierre Feugier,Catherine Thieblemont,Josée M. Zijlstra,Vincent Ribrag,Wolfram Klapper,Christiane Pott,Michael Unterhalt,Martin Dreyling

Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.

2019

PURPOSEIn an update of the randomized, open-label, phase III European Mantle Cell Lymphoma (MCL) Elderly trial (ClinicalTrials.gov identifier: NCT00209209), published in 2012, we aimed to confirm r...

Keywords:

Oncology
Internal medicine
Pathology
Medicine
Mantle cell lymphoma
long term follow up
Physical therapy
older patients

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations